Crown Bioscience Shows 3D Bone Marrow Model to Improve Blood Cancer Drug Testing and Reduce Animal Use

At the 2025 Annual Meeting of the American Association for Cancer Research (AACR)—a major international conference focused on cancer science …

Continue ›››

Moderna to Onboard R&D Teams to Benchling Platform for AI-Driven Research Integration

Benchling is expanding its collaboration with Moderna, which is now adopting the platform across its broader research organization. The rollout …

Continue ›››

Startup Working with Italian Hospitals Raises €2.2M to Structure Medical Reports into Care Plans

Milan-based startup ReportAId has raised €2.2 million in pre-seed funding to develop its AI platform aimed at converting unstructured medical …

Continue ›››

North Bristol NHS Trust Becomes Reference Site for FUJIFILM’s Digital Pathology Platform

North Bristol NHS Trust has been named the first European reference site for FUJIFILM Healthcare’s SYNAPSE Pathology system, marking a …

Continue ›››

Inductive Bio Raises $25M to Scale AI Platform for Predicting Drug Behavior Before Synthesis

Inductive Bio has secured $25 million in Series A financing to expand its machine learning platform for small molecule drug …

Continue ›››

Flagship Launches Etiome with $50M to Use AI for Stage-Specific Drug Target Discovery

Flagship Pioneering has launched Etiome, a biotechnology start-up focused on identifying and drugging biomarkers that correspond to specific stages of …

Continue ›››

Twist Bioscience Spins Out Atlas Data Storage with $155M to Commercialize DNA-Based Data Storage

Twist Bioscience has launched Atlas Data Storage as an independent company focused entirely on the development and commercialization of DNA …

Continue ›››

Lantern Pharma Advances AI-Guided Drug into Phase 1b/2 Trial for Triple Negative Breast Cancer

Lantern Pharma announced FDA clearance of its Investigational New Drug (IND) application for LP-184 in the treatment of triple negative …

Continue ›››

Recursion Reports Positive Early Trial Results for Familial Adenomatous Polyposis

Recursion has released early results from its ongoing Phase 1b/2 TUPELO trial evaluating REC-4881, an investigational MEK1/2 inhibitor, as a …

Continue ›››

How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment

An estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s. Without major medical breakthroughs, that number is …

Continue ›››

No Clear Winner: 7-Year Brain Study Tests Rival Theories of Consciousness

A global team of researchers has carried out what may be the most ambitious attempt yet to test two of …

Continue ›››

Nurix Debuts Foundation Model to Predict Novel Binders for Undruggable Targets

Nurix Therapeutics presented new data at the 2025 AACR Annual Meeting supporting the capabilities of its DEL-AI platform—a machine learning–powered …

Continue ›››